Fundraising FoxBoyu Capital
Private equityGrand Cayman · Growth–Late Stage · 7 people tracked
Also known as BOYU CAPITAL GROUP MANAGEMENT LTD. · BOYU CAPITAL MANAGEMENT (SINGAPORE) PTE. LTD. · BOYU CAPITAL MANAGEMENT LIMITED · BOYU REAL ESTATE FUND MANAGEMENT LTD.
Find your way into Boyu Capital
Sign up to see every warm intro you have to Boyu Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Boyu Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Team · 7 people
from public directories
What they invest in
from 5 of 8 portfolio companiesBiotech ×4Healthtech ×3Deep Tech ×2AI & Machine Learning ×1Retail Tech ×1SaaS ×1
HQs:United States×2
Investments · 8 tracked
founders shown can be your intro pathBy year:2021 · 12019 · 12018 · 22017 · 12016 · 16 dated
Insurance platform (NYSE: WDH)
Co-investorsATM CapitalZhenFundGaorong CapitalGaorong Ventures
Frontera Therapeutics is a biotechnology company engaged in therapeutic research and development, spanning translational medicine, clinical operations, and manufacturing.
BiotechDeep TechHealthtechBoston, US
Xinyan Li(CEO)
Co-investorsOrbiMedCreacion VenturesHongShan Capital Group6 Dimensions Capital
Abogen Biosciences is a clinical-stage biotechnology company developing RNA-based medicines, with in-house capabilities spanning the full mRNA drug development cycle including protein engineering, mRNA sequence design and synthesis, lipid nanoparticle delivery, formulation, and commercial-scale manufacturing.
BiotechDeep TechHealthtech
Bo Ying(Founder)
Co-investors5Y CapitalCoatue ManagementFuzhou Jiebao Rongan Venture CapitalQiming Venture PartnersSoftBank Vision FundGL Ventures+7 more
Antengene is a biopharmaceutical company that develops therapies for cancer, with a pipeline focused on hematologic malignancies and solid tumors including Claudin 18.2, CD73, PD-L1/4-1BB bispecific, and CD24-targeting candidates.
BiotechHealthtech
Jay Mei(Founder)
Co-investorsDecheng CapitalQiming Venture PartnersFountainVest Partners
Hong Kong-listed (2137.HK) biotech founded in 2018 developing infectious disease therapies, led by hepatitis B functional-cure programs.
Co-investorsARCH Venture Partners6 Dimensions CapitalBlue Pool CapitalSequoia Capital
Hong Kong-listed (HKEX: 2616) Chinese biopharmaceutical company developing oncology, immunology and inflammation therapies.
Co-investorsARCH Venture Partners6 Dimensions CapitalGICHillhouse CapitalSequoia CapitalWuXi Healthcare Ventures
Trax provides retail intelligence and execution software for global CPG brands, using image recognition to analyze shelf images and report on on-shelf availability, share of shelf, pricing, and promotional compliance.
AI & Machine LearningRetail TechSaaS
Gary Laben(Chief Executive Officer)inJoel Bar-El(Co-founder)Dror Feldheim(Co-founder)
Co-investors1802 VenturesDigital HorizonDigital Horizon VCHaymaker VenturesSingha VenturesSmart Partnership Capital+9 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 3
3 IPOs · showing 1Waterdrop IncNYSE: WDH
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Waterdrop Inc | 11.9% | $12.00 | May 2021 | $5.6B |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has Boyu Capital made?
- Boyu Capital has 8 tracked investments, 3 of which have exited.
- What stage does Boyu Capital invest at?
- Boyu Capital invests at the Growth, Late Stage stages.
- What sectors does Boyu Capital focus on?
- Boyu Capital focuses on Consumer, Crypto & Web3, Fintech, Healthtech.
- Where is Boyu Capital located?
- Boyu Capital is headquartered in Grand Cayman, HK.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Lightspeed Venture Partners is a global venture capital firm that backs founders from Seed through Series F and beyond, emphasizing deep, immersive partnerships with the companies it invests in.
Third Point Ventures is the venture capital arm of Third Point LLC, backing technology founders across the full corporate lifecycle and offering guidance, coaching, and connections.
Rakuten Capital is the corporate venture capital arm of Rakuten Group, a Tokyo-based global internet services company. Since 2013 it has invested in more than 90 companies worldwide and offers operational and strategic support to its portfolio.
Wellington Management is a global institutional asset manager whose Alternative Investments platform spans liquid alternatives/hedge funds and private investing strategies, with over $53B in alternative assets under management across roughly 50 strategies.